亚洲成人aⅴ综合_男人的天堂网址在线观看_日韩国产精品欧美尤物一区二区_超级性按摩中文字幕一级不长_在线观看精品国产福利片2019_中文字幕邻居人妻_最新流露出of高能预警CDwant_粉色视频高清视频版全集_产自拍视频在线_亚洲AV永久无码精品桃花岛知道

您好,歡迎光臨安諾倫(北京)生物科技商城!
全國服務(wù)熱線:400-965-8633
關(guān)注我們
  • 會員中心
  • 會員中心
    詢價列表
    0

    最新加入的商品

    0 件商品 合計(jì):¥ 0
  • 會員中心
    購物車

    最新加入的商品

    件商品 合計(jì):¥ 0

全部產(chǎn)品分類

優(yōu)勢品牌
當(dāng)前位置:首頁 > 資料中心 > 期刊雜志
首頁 上一頁 1 下一頁 末頁 總計(jì) 2 個記錄,共 1 頁。 跳轉(zhuǎn)到
關(guān)閉

Antibody Expression and Production (Cell Engineering)

Engineered antibodies currently represent over 30% of biopharmaceuticals in clinical trials and their total worldwide sales continue to increase significantly. The importance of antibody applications is reflected in their increasing clinical and industrial applications as well as in the progression of established and emerging production strategies. This volume provides detailed coverage of the generation, optimization, characterization, production and applications of antibody. It provides the necessary theoretical background and description of methods for the expression of antibody in microbial and animal cell cultures and in transgenic animals and plants. There is a strong focus on those issues related to the production of intrabodies, bispecific antibody and antibody fragments and also to novel applications in cancer immunotherapy.

立即下載
關(guān)閉

Therapeutic Antibody Engineering

The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas. Therapeutic antibody engineering examines all aspects of engineering monoclonal antibodies and analyses the effect that various genetic engineering approaches will have on future candidates. Chapters in the first part of the book provide an introduction to monoclonal antibodies, their discovery and development and the fundamental technologies used in their production. Following chapters cover a number of specific issues relating to different aspects of antibody engineering, including variable chain engineering, targets and mechanisms of action, classes of antibody and the use of antibody fragments, among many other topics. The last part of the book examines development issues, the interaction of human IgGs with non-human systems, and cell line development, before a conclusion looking at future issues affecting the field of therapeutic antibody engineering.
立即下載